6th Zurich Precision Oncology Symposium 2025

Подробнее о видео

This video captures the full session of our Precision Oncology Symposium 2025, held at the University Hospital Zurich. Leading experts from across Europe and beyond present groundbreaking insights into the evolving landscape of precision oncology — from pediatric cancer care and lymphoma to bioimage analysis, multi-omics modeling, and the role of p53 in cancer evolution and therapy. The symposium highlights innovative diagnostics, data science applications, and therapeutic strategies that are shaping the future of personalized cancer treatment.

00:00 – 05:46 – Introduction – Matthias Guckenberger and Thorsten Zenz
05:46 – 35:54 – Clinical needs in precision oncology for children – Nastassja Scheidegger
35:54 – 1:09:34 – INTeRCePT - POLAR (Lymphoma) – Thorsten Zenz
1:09:34 – 1:43:18 – Precise diagnosis as a prerequisite for precision oncology – Claudia Haferlach
1:43:18 – 1:49:47 – Welcome address – Beatrice Beck Schimmer
1:49:47 – 2:24:14 – Towards quantitative bioimage analysis at scale – Virginie Uhlmann
2:24:14 – 2:51:21 – (Low) noise-resistance of multi-omics survival models in cancer – Valentina Boeva
2:51:21 – 3:23:05 – Responsible research assessment – Wolfgang Huber
3:23:05 – 3:56:38 – Cellular crosstalk in the bone marrow niche – gene regulation in AML – Judith Zaugg
3:56:38 – 4:32:14 – Acute myeloid leukemia – Alexandre Theocharides
4:32:14 – 5:04:06 – Targeting cellular interactions in the tumor microenvironment for therapeutic intervention – Andreas Moor
5:04:06 – 5:38:37 – Deterministic evolution in p53 mutant cancer – Kasper Karlsson
5:38:37 – End – p53-based cancer therapy: strategies and challenges – Moshe Oren